Results 281 to 290 of about 1,190,584 (342)
LEAP-008: pembrolizumab plus lenvatinib after immunotherapy in non-small cell lung cancer. [PDF]
Fukuda K.
europepmc +1 more source
Decellularized liver extracellular matrix scaffolds provide a platform to study dormant liver‐metastatic colorectal cancer. They induce reversible dormancy, in combination with nutrient depletion and low dose chemotherapy, through cell cycle arrest and chemotherapy resistance.
Sabrina N. VandenHeuvel +13 more
wiley +1 more source
Downregulation of KHSRP enhances carboplatin sensitivity in non-small cell lung cancer. [PDF]
Wen B +7 more
europepmc +1 more source
Bioprinting Organs—Science or Fiction?—A Review From Students to Students
Bioprinting artificial organs has the potential to revolutionize the medical field. This is a comprehensive review of the bioprinting workflow delving into the latest advancements in bioinks, materials and bioprinting techniques, exploring the critical stages of tissue maturation and functionality.
Nicoletta Murenu +18 more
wiley +1 more source
Clinical stage II non-small cell lung cancer: can we "just give adjuvant therapy"? [PDF]
Jindani R +9 more
europepmc +1 more source
Six stereoisomeric ruthenium‐peptide conjugates were synthesized and characterized, which showed high potential in photoactivated chemotherapy (PACT) and proximity protein labeling. Abstract Amino acid chirality is known to influence the biological properties of peptide‐containing prodrugs.
Liyan Zhang +7 more
wiley +1 more source
NFAT5 Regulates IL8 to Promote Cell Growth and Migration in Non-Small Cell Lung Cancer. [PDF]
Chen J, Mei T, Wang J, Qin T, Huang D.
europepmc +1 more source
Metallofullerenol Sc3N@C80(OH)18 demonstrates strong radioprotective properties as a scavenger of both short‐ and long‐lived radicals. The study reveals protection of human erythrocytes from γ‐radiation–induced biochemical damage via post‐irradiation removal of primary and secondary reactive oxidants, supported by pulse radiolysis kinetics.
Jacek Grebowski +6 more
wiley +1 more source

